First AD

Second AD

Preferred Induction Regimen for Transplant-Eligible Patients with Newly-diagnosed Multiple Myeloma

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Video Series

Evolving Practices: Navigating Patient Care in Newly Diagnosed & R/R Multiple Myeloma

OncLive Insights

Guideline Recommendations for Risk Stratification 

Selecting Between Quadruplet Induction Regimens

Managing Adverse Events for Patients Receiving Quadruplet Induction Regimens

Selecting the Proper Maintenance Therapy

Exploring Minimal Residual Disease in Multiple Myeloma

Frontline Induction Therapy for Transplant-Ineligible or Transplant-Deferred Patients

Bispecific Antibody Therapies for Relapsed or Refractory Multiple Myeloma

Step-up Dosing with Bispecifics

Aligning Real-world and Clinical Trial Data

Adverse Event Management with Bispecifics

Dose Modifications with Bispecifics

Real-world Outcomes with Talquetamab

Operationalizing Bispecifics with Other Sites